NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/02/2026
Back to search
Official data from USPTO
EUROGENTEC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EUROGENTEC
ST13
US500000079328123Class
1, 5, 42
Filing
79328123
Registration
7265178
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
04/03/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
10/11/2021
Registration date
01/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/09/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
33
Owner location
BE
Examiner
BARRETT, LEAH N
Law office
L60
Current location
TMEG LAW OFFICE 106
Holders and representatives
Holders
KANEKA EUROGENTEC SA
Representatives
Burton S. Ehrlich Ladas & Parry LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparations and chemical reagentsall for scientific laboratory diagnosisanalysis and researchother than for medical and veterinary use
Class 5
Pharmaceutical and veterinary preparationsvaccinesproteinsplasmids and conjugates; oligonucleotides kits and reagentspeptides kits and reagentsantibody production kits and reagentsmolecular biology kits and reagents for medical usefor use in disease research and treatmentsqPCRcatalogue peptides and antibodiesassay kits; therapeutic (GMP) oligonucleotidescustom critical raw material (CRM) peptidesantibodies for medical or veterinary for use in disease research and treatments; in vitro transcribed RNA and recombinant proteinsplasmid DNA obtained by microbial fermentationfor preclinicalclinical and commercial use for pharmaceutical and veterinary preparations for use in disease research and treatments; disinfectants; chemical reagents for medical and veterinary purposes
Class 42
Research and development services on chemical products; services of analysis of chemical products; working on and evaluation of chemical synthesis
Publications
History of USPTO decisions and trademark events.
35 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/29/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/10/2024
FIMP
FINAL DISPOSITION PROCESSED
04/10/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/09/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/09/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/09/2024
GPNX
NOTIFICATION PROCESSED BY IB
10/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/24/2023
PUBO
PUBLISHED FOR OPPOSITION
10/24/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/04/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/20/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/23/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/22/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/22/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/30/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/10/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/10/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/22/2023
GNFR
FINAL REFUSAL E-MAILED
02/22/2023
CNFR
FINAL REFUSAL WRITTEN
02/22/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/24/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/24/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/24/2023
RFNT
REFUSAL PROCESSED BY IB
08/17/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/26/2022
RFRR
REFUSAL PROCESSED BY MPU
07/26/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/23/2022
CNRT
NON-FINAL ACTION WRITTEN
07/22/2022
DOCK
ASSIGNED TO EXAMINER
07/15/2022
MAFR
APPLICATION FILING RECEIPT MAILED
12/14/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/10/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/09/2021
Continuous trademark protection
Get notified about every new filing that threatens EUROGENTEC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.